Labcorp is now offering Roche Diagnostics' recently FDA-cleared Alzheimer’s disease blood test to help primary care doctors ...
Roche has revealed the data behind a positive phase 3 trial for its oral BTK inhibitor fenebrutinib in primary progressive ...
Roche has appointed leading Australian cancer researcher Prof Mark Dawson to lead its pharma Research and Early Development (pRED) division.
Roche has shared the numbers behind its phase 3 win in primary progressive multiple sclerosis (PPMS), linking its BTK ...
The Preeclampsia Foundation announced today the launch of a new educational resource to help obstetricians and gynecologists better understand the growing field of predictive and diagnostic tools in ...
A 10-year study shows that a multipronged approach using whole exome sequencing can improve diagnostic yield in patients with ...
Roche’s cobas® BV/CV PCR assay aims to address frequent misdiagnosis of bacterial vaginosis and Candida vaginitis. The duplex test detects both conditions from one swab with high specificity, enabling ...
Researchers have known for decades that different brands of lab machines produce different results. The fix is easy — but not ...
Fallopian tube cancer, a rare gynecologic cancer, is gaining awareness due to its potential origin for many high-grade serous ovarian cancers. New diagnostics improve early detection and treatment, ...
Amgen added to uncertainty surrounding the OX40 drug class by returning an autoimmune candidate to Kyowa Kirin. | Amgen added ...
About 1 million people are living with multiple sclerosis in the U.S., and about 10% of those have PPMS, making it the least common form of the disease.
A new diagnostic test developed by Indianapolis medical giants can help identify or rule out Alzheimer’s in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results